Following the results of the recent presidential election, AJMC® Co-Editors-in-Chief weigh in on the implications of this new chapter in health reform.
Am J Manag Care. 2016;22(11):711The results of the recent federal and statewide elections sent a clear message that significant changes in the direction of health policy are on the horizon. Yet, the underlying maladies that diminish length and quality of our lives remain. Our healthcare delivery system, one of several key contributors to population health, suffers from considerable inefficiency. Prices are too high, transparency is too low, and incentives among stakeholders are misaligned and often are not directed to improve patient-centered outcomes. For a panoply of reasons, individuals systematically underconsume clinical services that will enhance their well-being (missed opportunities) and haphazardly use hundreds of billions of dollars in services that contribute nothing or little to their health (waste). For decades, strides have been made to increase the efficiency of our system. Since 2010, the Affordable Care Act jumpstarted these efforts in many ways, such as by expanding coverage, better engaging consumers, and changing provider incentives for providers from a volume-driven system to a more efficient and quality-driven one. As a new chapter in health reform is upon us, we would like to think that the goals of improving the experience of care, improving the health of populations, and reducing per-capita spending on healthcare are shared by all stakeholders.
There is little doubt that new strategies to achieve the Triple Aim will be implemented. Doing so will require development and respect for evidence. Greater emphasis will likely be placed on innovative benefit design (eg, Health Savings Accounts [HSAs]) and, perhaps, relatively less on payment reform. Hopefully, experiments underway to assess innovative provider- and consumer-facing initiatives will continue, and the learnings of the past 5 years will not be lost. Payment reform models have been a modest success and further evaluation of existing alternative payment models should continue to inform transformation moving forward. Transparency tools may help, but currently, they are seldom used, which suggests that we have far to go before consumer-oriented strategies reach their potential. Innovation in benefit design must also continue. High levels of consumer cost sharing should be limited to clinical services that do not produce health to the consumer and situations where patients can shop among providers. Even then, increased out-of-pocket costs can impose risk—especially on those populations that are economically vulnerable or faced with chronic clinical conditions. Specifically, given the apparent priority role of HSAs in the Trump administration’s health policy agenda, regulatory barriers must be eliminated to allow health plans the flexibility to best serve the health of enrollees.1 HSA reform has broad multi-stakeholder and (very rare) bipartisan political support.2
Michael E. Chernew, PhD, and A. Mark Fendrick, MD, Co-Editors-in-Chief, The American Journal of Managed Care®
Americans deserve to get more health for their healthcare expenditures. There are no silver bullets to these complex issues. It is our hope that The American Journal of Managed Care® will continue to play a nonpartisan role in the healthcare transformation dialogue. REFERENCES
1. HSA-eligible high-deductible health plans. Center for Value-Based Insurance Design website. http://vbidcenter.org/initiatives/hsa-high-deductible-health-plans/. Accessed November 10, 2016.
2. Bipartisan “Access to Better Care Act” introduced to House of Representatives [press release]. Washington, DC: Center for Value-Based Insurance Design; July 7, 2016. http://vbidcenter.org/press-release-bipartisan-access-to-better-care-act-introduced-to-house-of-representatives/. Accessed November 10, 2016.  

HEDIS Glycemic Goal Achieved Using Control-IQ Technology
December 22nd 2025A greater proportion of patients with type 1 diabetes who used automated insulin delivery systems vs multiple daily injections achieved the Healthcare Effectiveness Data and Information Set (HEDIS) glycemic measure.
Read More
Linking Data to Determine Risk for 30-Day Readmissions in Dementia
December 22nd 2025This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30-day readmissions.
Read More
Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures
December 19th 2025Limiting health-related social needs screening to lower-income areas would reduce screening burdens; however, this study found a 2-stage screening approach based on geography to be suboptimal.
Read More
Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes
December 17th 2025Medicaid’s Institution for Mental Diseases (IMD) rule bars federal funding for psychiatric facilities with more than 16 beds, but findings indicate that state waivers allowing treatment of serious mental illness in IMDs do not increase overall psychiatric hospitalizations.
Read More
Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy
December 16th 2025The foundation of medically integrated pharmacy includes 7 critical pillars. This commentary focuses on the benefits of 3 of those pillars: abandonment, adherence, and access/affordability.
Read More